Fora Capital, LLC Royalty Pharma PLC Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$37.53 - $44.22 $1.15 Million - $1.35 Million	30,623 Added 292.73%	41,084 $1.73 Million
Q1 2022 May 12, 2022	BUY	$37.46 - $42.44 $391,869 - $443,964	10,461 New	10,461 $408,000
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $537,654 - $628,404	-14,877 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $592,848 - $693,714	14,877 New	14,877 $610 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $1.79 Million - $2.24 Million	-42,348 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $1.53 Million - $2.12 Million	42,348 New	42,348 $2.12 Million

398

291M

305K

138K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $12.3B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.